These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 32508878)

  • 41. Integrated bioinformatics analysis of core regulatory elements involved in keloid formation.
    Li C; Jin M; Luo Y; Jin Z; Pi L
    BMC Med Genomics; 2021 Oct; 14(1):239. PubMed ID: 34600545
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of hub genes and transcription factor-miRNA-mRNA pathways in mice and human renal ischemia-reperfusion injury.
    Ke P; Qian L; Zhou Y; Feng L; Zhang Z; Zheng C; Chen M; Huang X; Wu X
    PeerJ; 2021; 9():e12375. PubMed ID: 34754625
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of key miRNA-gene pairs in chronic lymphocytic leukemia through integrated analysis of mRNA and miRNA microarray.
    Li J; Qin Y; Zhang H
    Oncol Lett; 2018 Jan; 15(1):361-367. PubMed ID: 29285196
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Integrated analysis of multiple bioinformatics studies to identify microRNA-target gene-transcription factor regulatory networks in retinoblastoma.
    Wen Y; Zhu M; Zhang X; Xiao H; Wei Y; Zhao P
    Transl Cancer Res; 2022 Jul; 11(7):2225-2237. PubMed ID: 35966326
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of molecular targets for esophageal carcinoma diagnosis using miRNA-seq and RNA-seq data from The Cancer Genome Atlas: a study of 187 cases.
    Zeng JH; Xiong DD; Pang YY; Zhang Y; Tang RX; Luo DZ; Chen G
    Oncotarget; 2017 May; 8(22):35681-35699. PubMed ID: 28415685
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hsa-miR-137, hsa-miR-520e and hsa-miR-590-3p perform crucial roles in Lynch syndrome.
    Zhou C; Li J; Li J; Wan Y; Li T; Ma P; Wang Y; Sang H
    Oncol Lett; 2016 Sep; 12(3):2011-2017. PubMed ID: 27602130
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of a transcription factor-microRNA network in esophageal adenocarcinoma through bioinformatics analysis and validation through qRT-PCR.
    Chen D; Lu T; Tan J; Zhao K; Li Y; Zhao W; Li H; Wang Q; Wang Y; Wei L
    Cancer Manag Res; 2019; 11():3315-3326. PubMed ID: 31114367
    [No Abstract]   [Full Text] [Related]  

  • 48. Identification and interaction analysis of key genes and microRNAs in hepatocellular carcinoma by bioinformatics analysis.
    Mou T; Zhu D; Wei X; Li T; Zheng D; Pu J; Guo Z; Wu Z
    World J Surg Oncol; 2017 Mar; 15(1):63. PubMed ID: 28302149
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of key microRNAs associated with diffuse large B-cell lymphoma by analyzing serum microRNA expressions.
    Meng Y; Quan L; Liu A
    Gene; 2018 Feb; 642():205-211. PubMed ID: 29128636
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of Key Genes in Colorectal Cancer Regulated by miR-34a.
    Wang T; Xu H; Liu X; Chen S; Zhou Y; Zhang X
    Med Sci Monit; 2017 Dec; 23():5735-5743. PubMed ID: 29197895
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Exploring the molecular mechanisms of osteosarcoma by the integrated analysis of mRNAs and miRNA microarrays.
    Shen H; Wang W; Ni B; Zou Q; Lu H; Wang Z
    Int J Mol Med; 2018 Jul; 42(1):21-30. PubMed ID: 29620143
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Screening of potential biomarkers in the occurrence and development of type 1 diabetes mellitus based on transcriptome analysis.
    Kang J; Shen X; Yang L; Feng S; Li D; Yuan H
    Endokrynol Pol; 2020; 71(1):58-65. PubMed ID: 33140399
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MicroRNA network analysis identifies key microRNAs and genes associated with precancerous lesions of gastric cancer.
    Wang XW; Wu Y; Wang D; Qin ZF
    Genet Mol Res; 2014 Oct; 13(4):8695-703. PubMed ID: 25366760
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of hub genes with prognostic values in gastric cancer by bioinformatics analysis.
    Li T; Gao X; Han L; Yu J; Li H
    World J Surg Oncol; 2018 Jun; 16(1):114. PubMed ID: 29921304
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of key miRNAs in the progression of hepatocellular carcinoma using an integrated bioinformatics approach.
    Zheng Q; Wei X; Rao J; Zhou C
    PeerJ; 2020; 8():e9000. PubMed ID: 32411519
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification and comprehensive analysis of circRNA-miRNA-mRNA regulatory networks in osteoarthritis.
    Liu X; Xiao H; Peng X; Chai Y; Wang S; Wen G
    Front Immunol; 2022; 13():1050743. PubMed ID: 36700234
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An integrated analysis of key microRNAs, regulatory pathways and clinical relevance in bladder cancer.
    Li D; Hao X; Song Y
    Onco Targets Ther; 2018; 11():3075-3085. PubMed ID: 29872319
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of key miRNAs and their targets in peripheral blood mononuclear cells of IgA nephropathy using bioinformatics analysis.
    Liu L; Yang Y; Yu D
    Medicine (Baltimore); 2021 Jul; 100(26):e26495. PubMed ID: 34190177
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.
    Lou W; Liu J; Ding B; Chen D; Xu L; Ding J; Jiang D; Zhou L; Zheng S; Fan W
    J Transl Med; 2019 Jan; 17(1):7. PubMed ID: 30602391
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Construction and analysis of mRNA, miRNA, lncRNA, and TF regulatory networks reveal the key genes associated with prostate cancer.
    Ye Y; Li SL; Wang SY
    PLoS One; 2018; 13(8):e0198055. PubMed ID: 30138363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.